Stock Markets June 16, 2026 08:02 AM

ABF Shares Fall as Citi Flags Primark Sales Risk Ahead of July Trading Update

Citi's negative catalyst watch and a reduced price target weigh on Associated British Foods despite CMA clearance for Hovis deal

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn

Associated British Foods fell 1.6% to 1895.5p after Citi placed the stock on a negative catalyst watch and trimmed its price target, citing an expected 4% like-for-like sales decline at Primark in Q3 and a sequential slowdown versus the first half. The UK regulator cleared ABF’s purchase of Hovis without restrictions, but analyst concern about Primark’s near-term sales trajectory and a cautious consensus kept selling pressure on the shares ahead of a July 1 trading statement.

ABF Shares Fall as Citi Flags Primark Sales Risk Ahead of July Trading Update
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Citi placed ABF on a negative catalyst watch and lowered its price target to .10 from .50, while keeping a Sell rating.
  • Citi forecasts a 4% like-for-like sales decline at Primark in Q3, implying a sequential slowdown of roughly one percentage point versus the first half, which has weighed on investor sentiment.
  • The UK regulator cleared ABF’s acquisition of Hovis without restrictions, but the deal approval did not fully offset the negative analyst-driven pressure on the share price.

Associated British Foods (ABF) shares slipped 1.6% in today’s trading, ending the session at 1895.5p, after Citi moved the stock onto a negative catalyst watch and lowered its price target. The broker’s action intensified selling ahead of a closely watched Q3 trading statement scheduled for July 1, 2026.

Citi said it expects a 4% like-for-like sales decline at Primark in the third quarter, a weakness that would amount to a sequential slowdown of roughly one percentage point compared with the first half. The bank kept its Sell recommendation intact while cutting its price target to .10 from a prior .50.

On the corporate front, the UK Competition and Markets Authority granted unconditional approval for ABF’s proposed acquisition of bread maker Hovis today, removing the final regulatory obstacle to completing the transaction. The clearance, while significant for ABF’s deal timetable, did not counterbalance the downward pressure coming from the analyst revision.

Analyst sentiment around ABF was already skewed cautious before today’s move: the stock carried a consensus mix of 1 buy rating, 11 hold ratings, and 6 sell ratings from analysts. That prevailing conservatism, combined with Citi’s negative catalyst flag and the reduced price target, was sufficient to push the share price lower in the session.

Market context for the decline was mixed. The UK blue-chip FTSE 100 was trading around 10,430, down roughly 0.4% and pressured by sharp falls in major oil companies including Shell and BP, alongside weakness in defence and healthcare names. By contrast, the wider pan-European STOXX 600 was up about 0.5% by mid-session, hitting fresh record highs following a preliminary U.S.-Iran peace agreement announced by President Trump.

ABF’s drop stood out against the constructive performance on the continent. With the shares already well below their 52-week high of 2351p, investors appeared reluctant to look beyond the anticipated Q3 softness until the July 1 trading update provides clearer evidence on whether Primark’s sales are stabilising.


What to watch next

  • ABF’s Q3 trading statement due July 1, 2026 - the immediate data point investors are awaiting to assess Primark’s trajectory.
  • Any further analyst commentary or revisions ahead of the update that could amplify trading volatility.
  • Broader UK market moves tied to energy, defence and healthcare stocks that may influence sentiment toward domestic large caps.

Risks

  • Near-term sales weakness at Primark creating uncertainty for ABF- affects retail and consumer discretionary sectors.
  • Analyst downgrades and negative catalyst flags potentially triggering further selling pressure in ABF stock - impacts equities and investor sentiment in UK large caps.
  • Broader market weakness led by oil majors and defensive sectors could exacerbate share price volatility for ABF - ties to energy and healthcare sector movements.

More from Stock Markets

Parabilis Medicines Shares Rise After Directors and Major Investor Buy Stock Post-IPO Jun 16, 2026 UniCredit’s €40 billion bid for Commerzbank reaches scheduled close amid continued German opposition Jun 16, 2026 Alvotech shares drop after $152 million equity financing; existing holders face dilution Jun 16, 2026 CervoMed Shares Surge After Director Executes Large Purchase in Private Placement Jun 16, 2026 Norwegian Air Shares Slip After SEK 7.94 Billion Purchase of Nordic Leisure Travel Jun 16, 2026